Compound preparation of active ingredients of traditional Chinese medicine for treating vascular dementia and its application

A technology of vascular dementia and active ingredients, which is applied in the field of traditional Chinese medicine, can solve the problems of increased blood drug concentration and low oral bioavailability, and achieve the effects of slowing down the metabolism of acetylcholine, reducing cognitive dysfunction, and slowing down the generation of acetylcholine

Active Publication Date: 2021-03-23
GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although ginsenosides Rg3, Rg1, Re, Rf, and Rg2 have no significant increase in blood drug concentration after continuous administration [13], ginsenosides Rg1 and Re have the effect of protecting learning and memory, but ginsenosides Rg1, Rg3, and Re are easy to Degraded by enzymes produced by intestinal bacteria, oral bioavailability is very low [14-16]

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound preparation of active ingredients of traditional Chinese medicine for treating vascular dementia and its application
  • Compound preparation of active ingredients of traditional Chinese medicine for treating vascular dementia and its application
  • Compound preparation of active ingredients of traditional Chinese medicine for treating vascular dementia and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0074] A traditional Chinese medicine active ingredient compound preparation for treating vascular dementia, the compound preparation includes active ingredients and / or pharmaceutically acceptable adjuvants or carriers, and its active ingredients are composed of ginsenoside Rb3 and β-asarone, wherein the effective The ingredients are composed of 1-5 parts by weight of ginsenoside Rb3 and 1-5 parts by weight of beta-asarone.

Embodiment 2

[0076]An oral tablet for treating vascular dementia, the compound preparation includes active ingredients and / or pharmaceutically acceptable adjuvants or carriers, the active ingredients are composed of ginsenoside Rb3 and β-asarone, wherein the active ingredients are composed of 1 weight part of ginsenoside Rb3 and 1 weight part of β-asarone.

[0077] The raw and auxiliary materials are mixed, granulated, dried and pressed into tablets according to conventional methods.

Embodiment 3

[0079] An oral liquid for treating vascular dementia, the compound preparation includes active ingredients and / or pharmaceutically acceptable excipients or carriers, the active ingredients are composed of ginsenoside Rb3 and β-asarone, wherein the active ingredients are composed of 2 It consists of ginsenoside Rb3 in parts by weight and β-asarone in 3 parts by weight.

[0080] The raw and auxiliary materials are mixed according to a conventional method to prepare an oral liquid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of traditional Chinese medicines. The invention particularly discloses a traditional Chinese medicine effective component compound preparation for treatingvascular dementia and an application thereof. The compound preparation comprises effective components and / or pharmaceutically acceptable auxiliary materials or carriers. The compound preparation is characterized in that effective components consist of ginsenoside Rb3 and beta-asarone; and through the synergistic effect of the ginsenoside Rb3 and the beta-asarone, protection on nerve cells is effectively improved; generation of beta-like precipitated proteins and metabolism of acetylcholine are slowed down, damages caused by free radicals, apoptosis factors and the like are reduced, cognitiveimpairment caused by brain tissue apoptosis necrosis is obviously relieved, and cell apoptosis and cell oxidative stress reaction are inhibited. The compound preparation has a remarkable effect of preventing and treating vascular dementia, is less in medicine flavor and clear in action mechanism and is beneficial to quality control, and the medicine dosage is effectively reduced while the curativeeffect is ensured.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a compound preparation for treating vascular dementia and its application. Background technique [0002] Vascular dementia (VaD) is a clinical syndrome ranging from mild cognitive impairment to dementia on the basis of degeneration of brain cell function caused by various stroke-related factors[1]. VaD is a common senile disease in my country. The clinical manifestations are mainly memory loss and intellectual decline, accompanied by decreased living ability, emotional and behavioral abnormalities, etc. With the increasing aging of our population and the changes in diet structure and daily life, the incidence of stroke and heart disease is also increasing. In recent years, due to the blowout growth of cerebrovascular diseases, people pay more and more attention to the research of VaD. At present, post-stroke dementia has two meanings: ①stroke is the main di...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/704A61K31/09A61P25/28
CPCA61K31/09A61K31/704A61P25/28A61K2300/00
Inventor 邓敏贞
Owner GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products